Delivery Order SPE2DR25D2104-SPE2DR26F3TUK
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Fentanyl 37.5 mcg/hr patches in quantities of five units, valued at $1,118.52. This competitive award, made on October 21, 2025, with an ultimate completion date of October 22, 2025, utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger contract vehicle with DLA. The contractor, headquartered in Conshohocken, Pennsylvania, will perform at its...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Fentanyl Transdermal Patch 37.5 micrograms with a ceiling value of $7,063.91. This firm fixed price delivery order, with an ultimate completion date of December 17, 2025, represents a non-competitive procurement executed under the company's existing indefinite delivery contract vehicle. The award was made to AmerisourceBergen's corporate office...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Fentanyl Transdermal Patch 37.5 mcg with a ceiling value of $8,748.75. This firm fixed-price delivery order, with an ultimate completion date of August 28, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award utilized no set-aside designation and was competitively awarded through the federal...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Fentanyl 37.5 mcg/hr patches (5-count units) on November 12, 2025, with an ultimate completion date of November 13, 2025. The contract, valued at $2,382.35, is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $8.77K delivery order to AmerisourceBergen Drug Corp on January 9, 2026, for the supply of Fentanyl Transdermal Patch 37.5mcg, with final delivery required by January 12, 2026. This is a firm fixed-price, non-competitive delivery order that leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp,...
- The Defense Logistics Agency awarded a delivery order valued at $1,097.04 to AmerisourceBergen Drug Corp for the supply of Fentanyl 75 mcg/hr patches (quantity of 5 units). The contract is categorized as a firm fixed-price delivery order with an ultimate completion date of December 15, 2025, and carries no set-aside designation. This award was issued competitively and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency (DLA) awarded a $1,846.14 delivery order to AmerisourceBergen Drug Corp for Fentanyl 37.5 micrograms per hour transdermal patches (5-count units) on December 4, 2025, with an ultimate completion date of December 5, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a continuation of the...
- The Defense Logistics Agency awarded a delivery order valued at $7,037.29 to AmerisourceBergen Drug Corp for the supply of Fentanyl 100 mcg/hr patches (5 count) on July 14, 2025, with an ultimate completion date of July 15, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December...
- The U.S. Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Fentanyl Transdermal Patch 37.5 micrograms, with a ceiling value of $1,934.74. The contract, awarded on July 25, 2025, employs firm fixed-price pricing and is scheduled for completion by July 28, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order valued at $1,288.50 to AmerisourceBergen Drug Corp for Fentanyl 100 micrograms/2 milliliter transdermal patches on October 23, 2025, with an ultimate completion date of October 24, 2025. This non-set-aside, firm fixed-price delivery order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. As a child contract action, this delivery order is issued under AmerisourceBergen Drug Corp's larger...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3TUKDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,158.28 to AmerisourceBergen Drug Corp for Fentanyl 37.5 mcg/hr patches (quantity: 5) on January 16, 2026, with an ultimate completion date of January 20, 2026. This is a firm fixed-price contract with no set-aside designation, competitively awarded through open competition. The pharmaceutical product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031. This comprehensive IDC serves as the primary vehicle for delivering pharmaceutical products and medical supplies—including specialty medications, brand-name and generic drugs, vaccines, and medical devices—to support military healthcare programs globally. The award demonstrates AmerisourceBergen's continued role as a critical pharmaceutical distributor for federal medical procurement, particularly supporting the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 1/15/26 |